|
01 Dec 2020 |
Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
|
|
01 Dec 2020 |
Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio
|
|
28 Nov 2020 |
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
|
|
23 Nov 2020 |
Creation of a research partnership between Pierre Fabre and Y-Biologics for the development of new immunotherapies based on monoclonal antibodies
|
|
23 Nov 2020 |
Schrödinger Announces a Multi-Target Drug Discovery, Development, and Commercialization Collaboration with Bristol Myers Squibb
|
|
23 Nov 2020 |
Horizon Therapeutics plc and Halozyme Therapeutics, Inc. Enter Global Collaboration and License Agreement for ENHANZE® Technology
|
|
23 Nov 2020 |
Merck to Acquire OncoImmune
|
|
20 Nov 2020 |
Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement
|
|
19 Nov 2020 |
ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease
|
|
19 Nov 2020 |
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
|
|
18 Nov 2020 |
Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies
|
|
16 Nov 2020 |
Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases
|
|
12 Nov 2020 |
MorphoSys and Cherry Biolabs Announce licensing of Hemibody Technology
|
|
09 Nov 2020 |
Infinity Pharmaceuticals Presents New MARIO-1 Phase 1/1b Clinical Data at The Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
|
|
06 Nov 2020 |
OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
|
|
06 Nov 2020 |
Artiva Biotherapeutics and Affimed Announce Platform-to-Platform R&D Collaboration for Targeted Off-the-Shelf NK Cell Therapies
|
|
06 Nov 2020 |
Novo Nordisk to acquire Emisphere Technologies and obtain ownership of the Eligen® SNAC oral delivery technology
|
|
05 Nov 2020 |
Merck to Acquire VelosBio
|
|
03 Nov 2020 |
Fusion Pharmaceuticals Announces Collaboration with AstraZeneca to Develop and Commercialize Next-Generation Radiopharmaceuticals and Combination Therapies
|
|
02 Nov 2020 |
Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance Therapeutic Development
|
|
02 Nov 2020 |
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products
|
|
29 Oct 2020 |
Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company
|
|
28 Oct 2020 |
insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
|
|
26 Oct 2020 |
AnaptysBio and GlaxoSmithKline Amend Strategic Immuno-Oncology Collaboration
|
|
23 Oct 2020 |
Arixa Pharmaceuticals Announces Acquisition by Pfizer’s Hospital Business
|
